Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
301 - 350 out of 509Page size: 50
Sort by: 1st author
  1. Published

    Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

    Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., Ruilope, L. M. & FIGARO DKD Investigators, F. D. I., 2021, In: New England Journal of Medicine. 385, p. 2252-2263 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

    Pollock, C., Stefánsson, B., Reyner, D., Rossing, Peter, Sjöström, C. D., Wheeler, D. C., Langkilde, A. M. & Heerspink, H. J. L., 2019, In: The Lancet Diabetes and Endocrinology. 7, 6, p. 429-441 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A urinary proteome-based classifier for the early detection of decline in glomerular filtration

    Pontillo, C., Jacobs, L., Staessen, J. A., Schanstra, J. P., Rossing, Peter, Heerspink, H. J. L., Siwy, J., Mullen, W., Vlahou, A., Mischak, H., Vanholder, R., Zürbig, P. & Jankowski, J., 1 Sep 2017, In: Nephrology, Dialysis, Transplantation. 32, 9, p. 1510-1516 7 p., gfw239.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker

    Pontillo, C., Zhang, Z-Y., Schanstra, J. P., Jacobs, L., Zürbig, P., Thijs, L., Ramírez-Torres, A., Heerspink, H. J. L., Lindhardt, M., Klein, R., Orchard, T., Porta, M., Bilous, R. W., Charturvedi, N., Rossing, P., Vlahou, A., Schepers, E., Glorieux, G., Mullen, W., Delles, C. & 5 others, Verhamme, P., Vanholder, R., Staessen, J. A., Mischak, H. & Jankowski, J., Nov 2017, In: Kidney International Reports. 2, 6, p. 1066-1075 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria

    Poulsen, C. G., Rasmussen, D. G. K., Genovese, F., Hansen, T. W., Nielsen, S. H., Reinhard, H., von Scholten, B. J., Jacobsen, P. K., Parving, H. H., Karsdal, M. A., Rossing, Peter & Frimodt-Møller, M., 2023, In: PLoS ONE. 18, 3, e0283296.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Hypertension in patients with diabetes

    Poulsen, P. L., Hansen, K. W., G+ªde, P. H. & Rossing, Peter, 2009, In: Ugeskrift for læger. 171, 24, p. 2031-2034 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Major adverse renal events (MARE): A proposal to unifying renal endpoints

    Prischl, F. C., Rossing, Peter, Bakris, G., Mayer, G. & Wanner, C., 2021, In: Nephrology, Dialysis, Transplantation. 36, 3, p. 491–497 gfz212.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

    Provenzano, M., Jongs, N., Vart, P., Stefánsson, B. V., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International Reports. 7, 3, p. 436-443

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

    Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Mauricio, D., Jensen, M. T. & Alonso, N., 2022, In: Cardiovascular Diabetology. 21, 257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Improved Time in Glucose Range over One Year Is Associated with Reduced Albuminuria in Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes

    Ranjan, A., Rosenlund, S., Hansen, T. W., Rossing, Peter, Andersen, S. & Nørgaard, Kirsten, 2020, In: Diabetes. 69, S2

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  11. Published

    Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump– treated type 1 diabetes

    Ranjan, A. G., Rosenlund, S. V., Hansen, T. W., Rossing, Peter, Andersen, S. & Nørgaard, K., 2020, In: Diabetes Care. 43, 11, p. 2882-2885 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Higher collagen VI formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria

    Rasmussen, D. G. K., Hansen, Tine Willum, Von Scholten, B. J., Nielsen, S. H., Reinhard, H., Parving, H. H., Tepel, M., Karsdal, M. A., Jacobsen, P. K., Genovese, F. & Rossing, Peter, 2018, In: Diabetes Care. 41, 7, p. 1493-1500 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Non-invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls

    Rasmussen, I. K. B., Hasbak, P., von Scholten, B. J., Laursen, J. C., Zobel, E. H., Jorge Diaz, L., Holmvang, Lene, Ripa, Rasmus Sejersten, Rossing, Peter, Kjær, Andreas & Hansen, T. W., 2021, In: Diabetic Medicine. 38, 6, 16 p., e14517.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Liraglutide Reduces Cardiac Adipose Tissue in Type 2 Diabetes: A secondary analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Rasmussen, I. K. B., Zobel, E. H., Ripa, Rasmus Sejersten, Scholten, B. J. V., Curovic, V. R., Jensen, Jacob Kildevang, Kjær, Andreas, Hansen, T. W. & Rossing, Peter, 2021, In: Diabetes, Obesity and Metabolism. 23, 12, p. 2651-2659

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Increased sub-clinical coronary artery pathology in type 2 diabetes with albuminuria

    Rasmussen, I. K. B., Skriver-Moeller, A., Ripa, Rasmus Sejersten, Hasbak, P., Wasehuus, V. S., lvs502, lvs502, Zobel, E. H., Lassen, Martin Lyngby, Holmvang, Lene, Slomka, P., Rossing, Peter, Kjær, Andreas & Hansen, T. W., 2024, In: Diabetes. 73, 3, p. 490–496 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Diabetes mellitus, hypertension and albuminuria in rural Zambia: a hospital-based survey

    Rasmussen, J. B., Thomsen, J. A., Rossing, Peter, Parkinson, S., Christensen, Dirk Lund & Bygbjerg, Ib Christian, Sep 2013, In: Tropical Medicine & International Health. 18, 9, p. 1080-4 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension

    Rasmussen, J. B. J., Nordin, L. S., Thomsen, J. A., Rossing, Peter, Bygbjerg, Ib Christian & Christensen, Dirk Lund, 6 Jan 2016, In: Journal of Clinical Hypertension. 18, 1, p. 27–30 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria

    Rathcke, C. N., Persson, F., Tarnow, L., Rossing, Peter & drb459, drb459, 2009, In: Diabetes Care. 32, 2, p. 323-328 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

    Reinhard, H., Jacobsen, P. K., Lajer, M., Pedersen, N., Billestrup, Nils, Mandrup-Poulsen, Thomas, Parving, H. & Rossing, Peter, 1 Oct 2010, In: Diabetologica. 53, 10, p. 2129-33 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy

    Reinhard, H., Jacobsen, P. K., Lajer, M., Tarnow, L., Astrup, A. S., Kim, W. Y., Pedersen, N., Billestrup, Nils, Mandrup-Poulsen, Thomas, Parving, H. & Rossing, Peter, 2011, In: Nephron Clinical Practice. 118, 3, p. c309-c314 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria

    Reinhard, H., Nybo, M., Hansen, Peter Riis, Wiinberg, N., Kjær, Andreas, Petersen, C. L., Winther, Kaj, Parving, H., Rasmussen, L. M., Rossing, Peter & Jacobsen, P., 2011, In: Cardiovascular Diabetology. 10, p. 70

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Ripa, Rasmus Sejersten, Zobel, E. H., von Scholten, B. J., Jensen, Jacob Kildevang, Binderup, Tina, Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Circulation: Cardiovascular Imaging. 14, 7, 13 p., 012174.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

    Rosas, S. E., Ruilope, L. M., Anker, S. D., Pitt, B., Rossing, Peter, Bonfanti, A. A. C., Correa-Rotter, R., González, F., Munoz, C. F. J., Pergola, P., Umpierrez, G. E., Scalise, A., Scott, C., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 10, 10 p., 100704.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: A longitudinal follow-up study

    Rosenlund, S., Hansen, T. W., Andersen, S. & Rossing, Peter, Nov 2015, In: Diabetic Medicine. 32, 11, p. 1445-1452 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Effect of sensor-augmented pump treatment versus multiple daily injections on albuminuria: A 1-year randomized study

    Rosenlund, S., Hansen, Tine Willum, Rossing, Peter & Andersen, S., Nov 2015, In: Journal of Clinical Endocrinology and Metabolism. 100, 11, p. 4181-4188 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives

    Rossing, Peter, Persson, F. & Frimodt-Møller, M., 2018, In: Nephrologie et Therapeutique. 14 , Suppl 1, p. S31-S37

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy

    Rossing, Peter, Rossing, K., Gaede, P., Pedersen, Oluf Borbye & Parving, H., 2006, In: Diabetes Care. 29, 5, p. 1024-30 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

    Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Craig, J. C., Tunnicliffe, D. J., Tonelli, M. A., Cheung, M. & 2 others, Earley, A. & de Boer, I. H., 2022, In: Kidney International. 102, 5, p. 990-999 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    FIDELIO-DKD Investigators, F. I., 2022, In: Kidney International Reports. 7, 1, p. 36-45

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Subclassification of diabetes based on quantitative traits

    Rossing, Peter, 2018, In: Nature Reviews Nephrology. 14, p. 355-356

    Research output: Contribution to journal › Comment/debate › Research

  31. Published

    What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?

    Rossing, Peter & Persson, F., 2021, In: Advances in Chronic Kidney Disease. 28, 4, p. 290-297 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  32. Published

    Increasing ESKD in Diabetes in the Land Down Under: What Can Be Done, We Must Wonder

    Rossing, Peter, Frimodt-Moller, M. & Persson, F., 2019, In: American Journal of Kidney Diseases. 73, 3, p. 293-296

    Research output: Contribution to journal › Editorial › Research › peer-review

  33. Published

    The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    on behalf of the FLOW Steering Committee and FLOW Trial Investigators, O. B. O. T. F. S. C. A. F. T. I., 2023, In: Nephrology Dialysis Transplantation. 38, 9, p. 2041-2051 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  35. Published

    Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

    Rossing, Peter, 2022, In: Kidney International Supplements. 12, 1, p. 27-35 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  36. Published

    Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Rossing, Peter, Garweg, J. G., Anker, S. D., Osonoi, T., Pitt, B., Rosas, S. E., Ruilope, L. M., Zhu, D., Brinker, M., Finis, D., Leal, S., Schmelter, T. & Bakris, G., 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 894-898 5 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  37. Published

    Aldosterone Blockade Added to Renin-Angiotensin System Blockade to Reduce Albuminuria: A Path for Improved Renoprotection?

    Rossing, Peter & Persson, F., 2018, In: American Journal of the Medical Sciences. 355, 5, p. 407-408

    Research output: Contribution to journal › Editorial › Research

  38. Published

    Mineralocorticoid receptor antagonists for diabetic kidney disease

    Rossing, Peter, 2020, In: Clinical Journal of the American Society of Nephrology. 15, 12, p. 1696-1698 3 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  39. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., McGill, J. B., Rosas, S. E., Joseph, A., Gebel, M., Roberts, L., Scheerer, M. F., Bakris, G. L. & Agarwal, R., 2022, In: Diabetes Care. 45, 12, p. 2991-2998 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Billings, L. K., Green, J. B., Koya, D., Mosenzon, O., Pantalone, K. M., Ahlers, C., Lage, A., Lawatscheck, R., Scalise, A. & Bakris, G. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2989-2998 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

    Rossing, Peter, Bain, S. C., Bosch-Traberg, H., Sokareva, E., Heerspink, H. J. L., Rasmussen, S. & Mellbin, L. G., 2023, In: Cardiovascular Diabetology. 22, 11 p., 220.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial

    Rossing, Peter, Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Amod, A., Marre, M., Joseph, A., Lage, A., Scott, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Diabetes, Obesity and Metabolism. 24, 1, p. 125-134 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 2, p. 407-416 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Linking kidney and cardiovascular complications in diabetes—impact on prognostication and treatment: The 2019 Edwin Bierman award lecture

    Rossing, Peter, Persson, F., Frimodt-Møller, M. & Hansen, T. W., 2021, In: Diabetes. 70, 1, p. 39-50 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  45. Published

    Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease

    Rossing, Peter, Block, G. A., Chin, M. P., Goldsberry, A., Heerspink, H. J. L., McCullough, P. A., Meyer, C. J., Packham, D., Pergola, P. E., Spinowitz, B., Sprague, S. M., Warnock, D. G. & Chertow, G. M., Oct 2019, In: Kidney International. 96, 4, p. 1030-1036

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Clinical Features and Natural Course of Diabetic Nephropathy

    Rossing, Peter & Frimodt-møller, M., 2018, Diabetic Nephropathy: Pathophysiology and Clinical Aspects. Roelofs, J. J. & Vogt, L. (eds.). Springer, p. 21-32

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  47. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

    Rossing, Peter, Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., Macisaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Diabetes Care. 45, 4, p. 888-897 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trial

    Rossing, Peter, Strand, J., Avogaro, A., Becka, M., Kanefendt, F. & Otto, C., 2021, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 36, 12, p. 2263–2273

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. Published

    Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes

    Rossing, Peter, Groehl, F., Mernagh, P., Folkerts, K., Garreta-Rufas, A., Harris, J., Meredith, K., Carter, M., Åkerborg, Ö., Wanner, C. & Hobbs, F. D. R., 2023, In: Journal of Medical Economics. 26, 1, p. 935-943 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Precision Medicine and/or Biomarker Based Therapy in T2DM: Ready for Prime Time?

    Rossing, Peter, Frimodt-Møller, M. & Persson, F., 2023, In: Seminars in Nephrology. 43, 3, 151430.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 11 Next

ID: 12937790